First American Bank’s Jazz Pharmaceuticals JAZZ Stock Holding History

First American Bank’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-2,100	Closed	-$266K	–	222
2013 Q4	$266K	Buy	+2,100	New	+$217K	0.03%	161

Other funds holding JAZZ

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

WBC

Westpac Banking Corp Sydney, Australia $1.44B AUM 28.5% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

First American Bank's JAZZ Position: Q1 2014 in Review

First American Bank sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2014, closing a stake of 2,100 shares — an estimated $266K sold.

First American Bank first reported a position in JAZZ in Q4 2013 and held it in 1 quarter. The position peaked at $266K in Q4 2013. 318 funds tracked by Wall St. Rank hold JAZZ as of Q1 2014.

First American Bank reported no remaining Jazz Pharmaceuticals position as of Q1 2014 after selling out during the quarter.
First American Bank sold 2,100 Jazz Pharmaceuticals shares in Q1 2014, an estimated $266K.
First American Bank first reported a position in Jazz Pharmaceuticals in Q4 2013 and held it in 1 quarter.
First American Bank's Jazz Pharmaceuticals position peaked at $266K in Q4 2013.
318 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2014.

Based on First American Bank's 13F filing for Q1 2014, filed 15 Apr 2014.